These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39013076)

  • 21. Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
    Martín-Saavedra F; Ruiz-Hernández E; Escudero-Duch C; Prieto M; Arruebo M; Sadeghi N; Deckers R; Storm G; Hennink WE; Santamaría J; Vilaboa N
    Acta Biomater; 2017 Oct; 61():54-65. PubMed ID: 28801266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic-Covalent Hydrogel with NIR-Triggered Drug Delivery for Localized Chemo-Photothermal Combination Therapy.
    Sun P; Huang T; Wang X; Wang G; Liu Z; Chen G; Fan Q
    Biomacromolecules; 2020 Feb; 21(2):556-565. PubMed ID: 31804804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance.
    Yao C; Wang P; Li X; Hu X; Hou J; Wang L; Zhang F
    Adv Mater; 2016 Nov; 28(42):9341-9348. PubMed ID: 27578301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances of microneedles in hormone delivery.
    Nguyen TT; Nguyen TTD; Tran NM; Vo GV
    Biomed Pharmacother; 2022 Jan; 145():112393. PubMed ID: 34773762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain.
    Simpson RW; Wlodarczyk JH
    Diabetes Care; 2016 Sep; 39(9):1493-500. PubMed ID: 27311495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedle-based drug delivery systems for transdermal route.
    Pierre MB; Rossetti FC
    Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ROS and NIR-II-Responsive Hyaluronic Acid Microneedle Loaded With Baicalin Nanoparticles for Treatment of Psoriasis.
    Xia C; Fu X; Wang Q; Chen X; Chen J; Kang Y; Wang B
    Macromol Rapid Commun; 2024 Aug; 45(15):e2400136. PubMed ID: 38593288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D printed microneedles for insulin skin delivery.
    Pere CPP; Economidou SN; Lall G; Ziraud C; Boateng JS; Alexander BD; Lamprou DA; Douroumis D
    Int J Pharm; 2018 Jun; 544(2):425-432. PubMed ID: 29555437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-infrared light-controllable MXene hydrogel for tunable on-demand release of therapeutic proteins.
    Wang S; Zhang Z; Wei S; He F; Li Z; Wang HH; Huang Y; Nie Z
    Acta Biomater; 2021 Aug; 130():138-148. PubMed ID: 34082094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microneedle patch designs to increase dose administered to human subjects.
    Li W; Li S; Fan X; Prausnitz MR
    J Control Release; 2021 Nov; 339():350-360. PubMed ID: 34597745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal Insulin Delivery and Microneedles-based Minimally Invasive Delivery Systems.
    Hong Y; Yu H; Wang L; Chen X; Huang Y; Yang J; Ren S
    Curr Pharm Des; 2022; 28(39):3175-3193. PubMed ID: 35676840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioceramic microneedles with flexible and self-swelling substrate.
    Cai B; Xia W; Bredenberg S; Li H; Engqvist H
    Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication and characterisation of self-applicating heparin sodium microneedle patches.
    Arshad MS; Zafar S; Zahra AT; Zaman MH; Akhtar A; Kucuk I; Farhan M; Chang MW; Ahmad Z
    J Drug Target; 2021 Jan; 29(1):60-68. PubMed ID: 32649227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol.
    Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y
    Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seeing, Targeting and Delivering with Upconverting Nanoparticles.
    Jalani G; Tam V; Vetrone F; Cerruti M
    J Am Chem Soc; 2018 Sep; 140(35):10923-10931. PubMed ID: 30113851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.